Subscribe
Sign in
Home
Notes
USC CPBH
Archive
About
Latest
Top
Discussions
How to Read A Study
Before You Believe the Headline
2 hrs ago
•
Hussein Yassine
1
1
June 2026
Obicetrapib and the Biology of Alzheimer’s Prevention
BROADWAY showed a promising p-tau217 signal. The next test is whether a lipid drug can help the right biological population.
Jun 28
•
Hussein Yassine
7
5
2
Beyond Omega-3 supplements: What PreventE4 Taught Us About Omega-3s and the Brain
Alzheimer’s prevention may depend on how the brain metabolizes omega-3s.
Jun 21
•
Hussein Yassine
12
9
Of Mice and Men: The Rapamycin Problem in Alzheimer’s Prevention
Insights from tissue specific immune aging biomarkers
Jun 14
•
Hussein Yassine
3
2
3
Alzheimer’s Inflammation: Treating a Fire We Still Can’t Measure
The MINDFuL trial: A Case Study in the Missing Inflammation Biomarker
Jun 7
•
Hussein Yassine
10
2
3
May 2026
Taurine, ALZ-801, and the Long Road to an Alzheimer’s Drug
Why Alzheimer’s science demands both hope and caution
May 31
•
Hussein Yassine
10
11
3
While You Were Sleeping
How Your Brain Cleans Itself -- and What It Means for Alzheimer's
May 24
•
Hussein Yassine
12
2
Are the New Alzheimer's Drugs Really "Disease-Modifying"?
What the evidence supports about lecanemab and donanemab — and what it does not.
May 17
•
Hussein Yassine
23
11
9
What a New Study Gets Wrong About Fish Oil
And why association is not causation
May 10
•
Hussein Yassine
14
3
Meet the Brain's Immune System — and Why It's the Next Big Bet Against Alzheimer's
A drug designed to supercharge the brain's immune cells just failed its biggest clinical test; but all is not lost.
May 4
•
Hussein Yassine
14
4
3
April 2026
Use It or Lose It
How mental activity affects the risk of dementia
Apr 19
•
Hussein Yassine
9
1
The Vascular Side of Alzheimer's: A New Hypothesis for Why the Brain Bleeds
A fresh Perspective on vascular inflammation in AD
Apr 12
•
Hussein Yassine
14
3
3
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
